IQVIA Holdings (FRA:QTS) ROE % Adjusted to Book Value : 2.67% (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is IQVIA Holdings ROE % Adjusted to Book Value?

IQVIA Holdings's ROE % for the quarter that ended in Sep. 2024 was 16.42%. IQVIA Holdings's PB Ratio for the quarter that ended in Sep. 2024 was 6.14. IQVIA Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 2.67%.

IQVIA Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for IQVIA Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings ROE % Adjusted to Book Value Chart

IQVIA Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

0.62

0.81

1.89

2.91

3.35

IQVIA Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															3.40	4.62	2.56	3.89	2.67

Competitive Comparison of IQVIA Holdings's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, IQVIA Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IQVIA Holdings's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's ROE % Adjusted to Book Value falls into.

IQVIA Holdings ROE % Adjusted to Book Value Calculation

IQVIA Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	22.55%	/	6.74
	=	3.35%

IQVIA Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	16.42%	/	6.14
	=	2.67%

IQVIA Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

IQVIA Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (FRA:QTS) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

IQV:USA IQV:Mexico 0JDM:UK I1QV34:Brazil IQVH:Austria

Address

2400 Ellis Road, Durham, NC, USA, 27703

Website

https://www.iqvia.com

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.